Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease-Reference-Cited by-同舟云学术

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

Published:1995-12 Issue:17 Volume:76 Page:1259-1265
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Barr Craig S.,Lang Chim C.,Hanson Jacqueline,Arnott Michael,Kennedy Norman,Struthers Allan D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Captopril in heart failure: a double-blind controlled trial;Cleland;Br Heart J,1984

2. Effects of intravenous magensium sulphate on arrhythmias in patients with congestive heart failure;Gottlieb;Am Heart J,1993

3. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease;Bashir;Am J Cardiol,1993

4. Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites;Stergiou;Miner Electrolyte Metab,1993

5. Catecholamine-mediated constrictor effects of aldosterone on vascular smooth muscle;Weber;Life Sci,1982

Cited by 274 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of mineralocorticoid receptor antagonists as a treatment option for patients with heart failure: the current state-of-the-art and future outlook;Expert Opinion on Pharmacotherapy;2022-10-13

2. Prognostic relevance of magnesium alterations in patients with a myocardial infarction and left ventricular dysfunction: insights from the EPHESUS trial;European Heart Journal. Acute Cardiovascular Care;2022-01-11

3. Clinical and genetic approach to renal hypomagnesemia;Biomedical Journal;2021-11

4. Aldosterone Blockade in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis;Cardiovascular Therapeutics;2021-10-25

5. Use of mineralocorticoid receptor antagonist in ST elevation myocardial infarction;Journal of Nuclear Cardiology;2021-09-13